lead has been researched along with gsk-j4 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brancale, A; Chalmers, IW; Ferla, S; Forde-Thomas, J; Geyer, KK; Hoffmann, KF; Hulme, BJ; Padalino, G; Whatley, KCL; Whiteland, H | 1 |
1 other study(ies) available for lead and gsk-j4
Article | Year |
---|---|
The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets.
Topics: Animals; Anthelmintics; Benzazepines; Computational Biology; Dose-Response Relationship, Drug; Drug Repositioning; Epigenesis, Genetic; Female; Genomics; Hep G2 Cells; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lead; Male; Models, Molecular; Molecular Docking Simulation; Oviposition; Pyrimidines; Schistosoma mansoni; Schistosomatidae; Schistosomiasis; Schistosomiasis mansoni | 2019 |